Xiao R

ORCID: 0000-0002-1430-4617 · 5 papers in corpus
other 2025
Scientific reports ·doi:10.1038/s41598-025-93010-8

Sepsis represents a significant global health challenge, necessitating early detection and effective treatment for improved outcomes. While traditional inflammatory markers facilitate the diagnosis of sepsis, the aspect of immune suppressio…

observational 2025
Journal of gynecologic oncology ·doi:10.3802/jgo.2025.36.e126

OBJECTIVE: To address the relation among pelvic inflammatory disease (PID), genetic vulnerability and ovarian cancer (OC) risk, we assessed the association between PID and OC risk, alongside the interplay with germline homologous recombinat…

rct 2024
American journal of translational research ·doi:10.62347/dsmc5610

OBJECTIVES: To investigate the effects of music combined with dexmedetomidine on perioperative anxiety and postoperative recovery in gynecologic laparoscopic patients. METHODS: A total of 82 female patients were enrolled in this study. Pat…

lab-animal 2022
Frontiers in pharmacology ·doi:10.3389/fphar.2022.973182

Background: Peritoneal fibrosis (PF) is an intractable complication in patients on long-term peritoneal dialysis (PD). Transforming growth factor-β (TGF-β) is a key pro-fibrogenic factor involved in PD-associated PF, and endoglin, as a core…

review 2016
Journal of hematology & oncology ·doi:10.1186/s13045-016-0236-7

Cancer is currently one of the leading causes of death worldwide and is one of the most challenging major public health problems. The main challenges faced by clinicians in the management and treatment of cancer mainly arise from difficulti…